Schawo, Saskia <br/><br/>
Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?  [electronic resource] 

 -  PharmacoEconomics  May 2015 
 - 489-509 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1179-2027 
<br/><br/><label>Standard No.: </label>10.1007/s40273-015-0259-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Attention Deficit Disorder with Hyperactivity--drug therapy<br/>Central Nervous System Stimulants--administration & dosage<br/>Child<br/>Cost-Benefit Analysis<br/>Delayed-Action Preparations--economics<br/>Humans<br/>Markov Chains<br/>Methylphenidate--administration & dosage<br/>Models, Economic<br/>Osmosis<br/>Patient Compliance<br/>Quality-Adjusted Life Years<br/>Treatment Outcome